HXBM (Helix Biomedix) Total Liabilities: $0.55 Mil (As of Sep. 2012)


What is Helix Biomedix Total Liabilities?

Helix Biomedix HXBM Total Liabilities is $0.55 Mil as of Sep. 2012.

Helix Biomedix's Total Liabilities for the quarter that ended in Sep. 2012 was $0.55 Mil.

Helix Biomedix's quarterly Total Liabilities declined from Mar. 2012 ($0.51 Mil) to Jun. 2012 ($0.33 Mil) but then increased from Jun. 2012 ($0.33 Mil) to Sep. 2012 ($0.55 Mil).

Helix Biomedix's annual Total Liabilities declined from Dec. 2009 ($7.18 Mil) to Dec. 2010 ($0.35 Mil) but then increased from Dec. 2010 ($0.35 Mil) to Dec. 2011 ($0.44 Mil).

Helix Biomedix Total Liabilities Historical Data

* Premium members only.

The historical data trend for Helix Biomedix's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Helix Biomedix Total Liabilities Chart

Helix Biomedix Annual Data
Trend Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.35 4.42 7.18 0.35 0.44

Helix Biomedix Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.44 0.51 0.33 0.55

Helix Biomedix Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Helix Biomedix's Total Liabilities for the fiscal year that ended in Dec. 2011 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.411+(0+-0.00099999999999998
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0.029+0+0)
=0.44

Total Liabilities=Total Assets (A: Dec. 2011 )-Total Equity (A: Dec. 2011 )
=2.975-2.535
=0.44

Helix Biomedix's Total Liabilities for the quarter that ended in Sep. 2012 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.52+(0+2.7755575615629E-17
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0.032+0+0)
=0.55

Total Liabilities=Total Assets (Q: Sep. 2012 )-Total Equity (Q: Sep. 2012 )
=1.702-1.15
=0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $0.55 Mil mean?
Helix Biomedix (HXBM) has a Total Liabilities of $0.55 Mil as of Sep. 2012. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Helix Biomedix and its competitors.
Is Helix Biomedix's Total Liabilities too high?
Helix Biomedix's current Total Liabilities is $0.55 Mil.
How does Helix Biomedix's Total Liabilities compare to XBIO and CBLI?
Helix Biomedix's Total Liabilities of $0.55 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Helix Biomedix and its competitors. Helix Biomedix's current Total Liabilities is $0.55 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Helix Biomedix stock overvalued right now?
Helix Biomedix (HXBM) has a current Total Liabilities of $0.55 Mil. The current Total Liabilities is $0.55 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Helix Biomedix (HXBM), the current Total Liabilities is $0.55 Mil as of Sep. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Helix Biomedix Business Description

Address 19125 North Creek Parkway, Suite 120, Bothell, WA, USA, 98011
Helix Biomedix Inc is a Delaware-based biopharmaceutical company that focuses on the early-stage development of peptide-based therapeutics for dermatology and skin health. The Company is in the preclinical stage, advancing a rare disease drug program for xeroderma pigmentosum, and plans to seek orphan drug designation before entering clinical development. Leveraging its proprietary peptide technology, Helix BioMedix aims to address unmet needs in rare dermatological conditions and has a history of developing patented bioactive peptides for topical personal care use.